Rxsight Inc Quick Ratio (RXST) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Rxsight Inc   (NASDAQ: RXST)

Rxsight Inc 's Quick Ratio

RXST's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 3.4 below Rxsight Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Quick Ratio than Rxsight Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 586, from total ranking in the second quarter 2026 at 735.

Explain Quick Ratio?
How much Cash & cash equivalents RXST´s has?
What are RXST´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RXST/financial-strength
https://api.csimarket.com/api/v1/companies/RXST/fundamentals
https://api.csimarket.com/api/v1/companies/RXST/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
RXST Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 236.24 %
Y / Y Cash & cash equivalent Change 11.94 %
Quick Ratio MRQ 3.4
RXST's Total Ranking # 586
Seq. Current Liabilities Change -6.83 %
Seq. Cash & cash equivalent Change -37 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 51
Healthcare Sector # 380
Overall Market # 1033


Quick Ratio Statistics
High Average Low
18.34 8.22 0.09
(Sep 30 2021)   (Dec 31 2022)




Financial Statements
Rxsight Inc 's Current Liabilities $ 75 Millions Visit RXST's Balance sheet
Rxsight Inc 's Cash & cash equivalent $ 255 Millions Visit RXST's Balance sheet
Source of RXST's Sales Visit RXST's Sales by Geography


Cumulative Rxsight Inc 's Quick Ratio

RXST's Quick Ratio for the trailling 12 Months

RXST Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 132.82 %
Y / Y Cash & cash equivalent TTM Growth 19.9 %
Quick Ratio TTM 5.2
Total Ranking TTM # 3838
Seq. Current Liabilities TTM Growth 32.94 %
Seq. Cash & cash equivalent TTM Growth 2.52 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $74.95 millions, cumulative Quick Ratio decreased to 5.2 above the RXST average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Rxsight Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 1921 to 3838.

Explain Quick Ratio?
How much Cash & cash equivalents RXST´s has?
What are RXST´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 885
Within the Market # 3838


trailing twelve months Quick Ratio Statistics
High Average Low
3.77 1.44 0.55
(Mar 31 2022)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Delcath Systems Inc   8.01 $ 104.315  Millions$ 13.022  Millions
Orchestra Biomed Holdings Inc   7.16 $ 101.907  Millions$ 14.228  Millions
Envveno Medical Corporation  7.13 $ 18.472  Millions$ 2.589  Millions
Ceribell Inc   6.51 $ 117.467  Millions$ 18.034  Millions
Autonomix Medical Inc   6.13 $ 7.692  Millions$ 1.254  Millions
Iradimed Corporation  6.13 $ 63.288  Millions$ 10.323  Millions
Orasure Technologies Inc  5.90 $ 148.238  Millions$ 25.104  Millions
Perspective Therapeutics Inc   5.09 $ 201.695  Millions$ 39.602  Millions
Clearpoint Neuro Inc   4.68 $ 46.184  Millions$ 9.869  Millions
Cvrx inc   4.67 $ 58.746  Millions$ 12.583  Millions
Dexcom Inc   4.25 $ 964.800  Millions$ 227.000  Millions
Innovative Eyewear Inc   3.86 $ 3.197  Millions$ 0.829  Millions
Sight Sciences Inc   3.84 $ 77.402  Millions$ 20.137  Millions
Alpha Pro Tech Ltd   3.78 $ 25.546  Millions$ 6.750  Millions
Hyperfine Inc   3.60 $ 37.872  Millions$ 10.532  Millions
Profound Medical Corp   3.41 $ 33.343  Millions$ 9.771  Millions
Rxsight Inc   3.40 $ 254.683  Millions$ 74.952  Millions
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions
Trisalus Life Sciences Inc   3.15 $ 41.057  Millions$ 13.014  Millions
Procept Biorobotics Corporation  3.10 $ 218.369  Millions$ 70.353  Millions
Carlsmed Inc   3.08 $ 56.207  Millions$ 18.237  Millions
Outset Medical Inc   3.07 $ 136.627  Millions$ 44.453  Millions
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions

Date modified: 2026-11-04T15:25:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.